Clinical Studies Sponsored by BioNTech | 5 results

Name	Description	NCT Number	Clinical Trial Start Date	Study Completion Date	Clinical Trial Study Type
‌ A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy and Immunocompromised Adults	Clinical trial NCT04380701 is a trial investigating the safety and effects of four BNT162 vaccines against COVID-2019 in healthy adults.	NCT04380701	April 23, 2020	August 1, 2020	Interventional
‌ Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals	The trial (NCT04368728) is an intervention trial that tests the efficacy of candidate vaccines against SARS-CoV-2, the novel coronavirus that causes COVID-19 disease.	NCT04368728	April 29, 2020	December 11, 2022	Interventional
‌ Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects		NCT04523571	July 28, 2020	August 1, 2021	Interventional
‌ Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults		NCT04588480	October 21, 2020	November 30, 2021	Interventional
‌ A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults		NCT04537949	September 9, 2020	December 2021	Interventional